BRIEF published on 06/07/2024 at 08:28, 1 year 9 months ago Assemblée générale mixte de Biophytis le 24 juin 2024 Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
BRIEF published on 06/07/2024 at 08:28, 1 year 9 months ago Biophytis Announces Combined General Meeting on June 24, 2024 Shareholders Biophytis General Meeting Voting Agenda
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 1 year 9 months ago Assemblée générale mixte du 24 juin 2024 Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 1 year 9 months ago Combined General Meeting of June 24, 2024 Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website Shareholders Voting Combined General Meeting Biophytis SA CGM
BRIEF published on 06/07/2024 at 07:44, 1 year 9 months ago Assemblée générale mixte de Biophytis prévue le 24 juin 2024 Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF published on 06/07/2024 at 07:44, 1 year 9 months ago Biophytis Combined General Meeting scheduled for June 24, 2024 Shareholders Biophytis Paris General Assembly Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 1 year 9 months ago Assemblée générale mixte du 24 juin 2024 Biophytis tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont invités à voter en amont par différents moyens. Infos sur le site web de la société Actionnaires Biophytis Assemblée Générale Société De Biotechnologie Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 1 year 9 months ago Combined General Meeting of June 24, 2024 Biophytis to hold Combined General Meeting (CGM) on June 24, 2024 at Sorbonne Université. Shareholders urged to vote in advance. Company specializes in age-related disease therapeutics Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
BRIEF published on 05/14/2024 at 07:05, 1 year 10 months ago Biophytis lance une étude clinique phase 2 pour traiter l'obésité Biophytis Étude Clinique Phase 2 BIO101 Obésité
BRIEF published on 05/14/2024 at 07:05, 1 year 10 months ago Biophytis Unveils Phase 2 OBA Clinical Study Design in Obesity Biophytis Obesity Treatment Clinical Trial BIO101 OBA Clinical Study
Published on 03/24/2026 at 13:30, 3 hours 1 minute ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 3 hours 1 minute ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 3 hours 56 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 3 hours 58 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 4 hours 1 minute ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 16:14, 17 minutes ago TenneT Germany receives preliminary inaugural S&P credit rating of BBB+ with stable outlook
Published on 03/24/2026 at 16:10, 20 minutes ago EQS-Adhoc: IONOS Group SE decides to launch new share buyback program
Published on 03/24/2026 at 16:02, 29 minutes ago EQS-Adhoc: JENOPTIK AG: Dr. Dominic Dorfner to become new CEO of JENOPTIK AG
Published on 03/24/2026 at 16:01, 29 minutes ago Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy
Published on 03/24/2026 at 10:58, 5 hours 33 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 5 hours 33 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 8 hours 46 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 8 hours 46 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 9 hours 1 minute ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
